ニューロサイエンスの世界市場規模、シェア、産業動向分析レポート：コンポーネント別、技術別、エンドユーザー別、地域別展望と予測、2023年～2030年

ニューロサイエンス市場規模は2030年までに640億米ドルに達し、予測期間中にCAGR 5.5%の市場成長率で上昇すると予測されます。

KBV Cardinalのマトリックスに掲載された分析によると、Danaher CorporationとAbbott Laboratoriesが市場の先駆者です。Terumo Corporation、Medtronic PLC、Stryker Corporationなどの企業は、この市場における主要なイノベーターです。2023年4月、Medtronic PLCはQure.aiと提携し、インド市場で脳卒中管理の先進ソリューションを提供します。

COVID-19の影響分析

COVID-19パンデミックは世界経済に深刻な影響を与えました。この大流行は、プラスにもマイナスにも、ほとんどすべての産業に影響を与えました。パンデミック発生当初、市場はマイナスの影響を受けた。ほとんどの国が、パンデミックのために精神衛生サービスを改善しなければならないというプレッシャーに直面しました。後期段階の医薬品パイプラインが確立されていたにもかかわらず、COVID-19のパンデミックは臨床試験手順、研究開発、パイプライン製品にも支障をきたし、これらの要因は市場の成長にマイナスの影響を及ぼしました。したがって、初期段階における市場へのマイナスの影響にもかかわらず、市場は今後数年間で急成長を遂げると思われます。

市場成長要因

治療および神経画像診断に対する有利な償還制度

先進国におけるヘルスケアインフラへの政府支出の増加は、市場の成長を促進すると予測されます。例えば、メディケア・メディケイド・サービスセンターによると、2021年のメディケア支出は8.4％増の9,008億米ドル、国民医療費（NHE）全体の21％に達し、メディケイド支出は9.2％増の7,340億米ドル、NHE全体の17％に達します。米国では、このような政府支出の増加傾向により、脳医療機器を含むすべての医療機器への関心が高まる。したがって、ほとんどの国で神経科学治療の償還が可能であることは、市場の成長を推進する重要な要因です。

神経科学研究開発活動の発展

最も効果的な画像診断および神経科学研究ツールは磁気共鳴画像法（MRI）です。中枢神経系（CNS）の卓越した機能的詳細に加え、最高品質の空間分解能と比類のない軟部組織のコントラストによる形態学的画像を提供します。"A Novel Brain-Computer January 2021 publish of"Interface Virtual Environment for Neurofeedback During Functional MRI"（機能的MRI中のニューロフィードバックのためのインターフェース仮想環境）と題する研究調査によると、新しいリアルタイム機能的MRI（rt-fMRI）ベースのニューロフィードバック（NF）トレーニングパラダイムを開発・実施するプロジェクトが開始されました。そのため、この分野での研究開発の高まりが市場成長の原動力になると予想されます。

市場抑制要因

脳の複雑さ

脳は、人間の他の臓器と比較して最も複雑です。調査によると、ヒトゲノムのかなりの部分が脳の構造、結合パターン、神経化学の発達に寄与しています。脳は、運動の誘発、感覚の仲介、他の身体器官の制御など、多くの機能を担っています。その作動は、知覚、認知、感情、創造的表現の基礎を提供します。神経科学はまた、環境や遺伝的変数によってもたらされる個人差も説明する必要があります。したがって、これらのコンポーネントがどのように相互作用し、さまざまな脳プロセスに寄与するかという複雑さが、市場拡大を制限する大きな障害となっています。

コンポーネントの展望

コンポーネントに基づき、市場は機器、消耗品、ソフトウェア＆サービスに区分されます。2022年には、機器セグメントがn市場を独占し、最大の収益シェアを占めました。このセグメントの成長は、神経疾患の検出と治療のための新しい機器装置の登場によるものです。神経科学で使用される機器の具体的な種類は、オプトジェネティクス機器です。その他の種類としては、顕微鏡装置、電気生理学的装置、MRI装置などがあります。

技術展望

技術別に見ると、市場は脳イメージング、神経顕微鏡、定位固定手術、神経プロテオミクス解析、神経細胞操作、その他に細分化されます。神経顕微鏡セグメントは2022年に大きな収益シェアを獲得しました。神経顕微鏡の需要は、遺伝子細胞ラベリングやオプトジェネティクスのような分野での技術開発率の増加により高まっています。神経系を細胞レベル、サブセルレベルで観察し、あらゆる分子修飾を脈絡づけるためには、顕微鏡技術が不可欠です。

エンドユーザーの展望

エンドユーザー別では、市場は病院、診断ラボ、研究・学術機関に分類されます。2022年には、診断ラボ部門が市場で最も高い収益シェアを記録しました。診断検査室における神経学的装置の応用範囲の広さと、早期疾病診断の利点に対する一般市民の意識の高まりが、このセグメントの成長の要因となっています。脳波（EEG）、筋電図（EMG）、CTスキャン、MRI、その他の神経学的診断ツールの使用は、診断施設では一般的です。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、北米地域が市場で最大の収益シェアを占めました。この地域における市場の成長は、神経患者の診断と治療に使用される技術の開発、製造、販売に携わる企業がこの地域に集中していることに起因しています。この地域における市場拡大の主な促進要因は、疾病の蔓延と認知度の上昇、および主要市場参入企業の存在です。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第4章 競合分析- 世界

• KBV Cardinal Matrix
• 最近の業界全体の戦略的展開
  • パートナーシップ、コラボレーション、および契約
  • 製品の発売と製品の拡大
  • 買収と合併
  • 試験と承認
• 主要成功戦略
  • 主な戦略
  • 主要な戦略的動き
• ポーターファイブフォース分析

第5章 世界の神経科学市場：コンポーネント別

• 世界の計測器市場：地域別
• 世界の消耗品市場：地域別
• 世界のソフトウェアおよびサービス市場：地域別

第6章 世界の神経科学市場：技術別

• 世界の脳画像市場：地域別
• 世界の定位固定手術市場：地域別
• 世界の神経顕微鏡市場：地域別
• 世界の神経プロテオーム解析市場：地域別
• 世界の神経細胞操作市場：地域別
• 世界のその他の市場：地域別

第7章 世界の神経科学市場：エンドユーザー別

• 世界の診断研究所市場：地域別
• 世界の病院市場：地域別
• 世界の調査および学術機関市場：地域別

第8章 世界の神経科学市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第9章 企業プロファイル

• Carl Zeiss AG
• Danaher Corporation
• Abbott Laboratories
• Koninklijke Philips NV
• B Braun Melsungen AG
• Medtronic PLC
• Boston Scientific Corporation
• Terumo Corporation
• GE HealthCare Technologies, Inc
• Stryker Corporation

第10章 神経科学市場における勝利の必須条件

LIST OF TABLES

• TABLE 1 Global Neuroscience Market, 2019 - 2022, USD Million
• TABLE 2 Global Neuroscience Market, 2023 - 2030, USD Million
• TABLE 3 Partnerships, Collaborations and Agreements- Neuroscience Market
• TABLE 4 Product Launches And Product Expansions- Neuroscience Market
• TABLE 5 Acquisition and Mergers- Neuroscience Market
• TABLE 6 Trials and Approvals- Neuroscience Market
• TABLE 7 Global Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 8 Global Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 9 Global Instruments Market by Region, 2019 - 2022, USD Million
• TABLE 10 Global Instruments Market by Region, 2023 - 2030, USD Million
• TABLE 11 Global Consumables Market by Region, 2019 - 2022, USD Million
• TABLE 12 Global Consumables Market by Region, 2023 - 2030, USD Million
• TABLE 13 Global Software & Services Market by Region, 2019 - 2022, USD Million
• TABLE 14 Global Software & Services Market by Region, 2023 - 2030, USD Million
• TABLE 15 Global Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 16 Global Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 17 Global Brain Imaging Market by Region, 2019 - 2022, USD Million
• TABLE 18 Global Brain Imaging Market by Region, 2023 - 2030, USD Million
• TABLE 19 Global Stereotaxic Surgeries Market by Region, 2019 - 2022, USD Million
• TABLE 20 Global Stereotaxic Surgeries Market by Region, 2023 - 2030, USD Million
• TABLE 21 Global Neuro-Microscopy Market by Region, 2019 - 2022, USD Million
• TABLE 22 Global Neuro-Microscopy Market by Region, 2023 - 2030, USD Million
• TABLE 23 Global Neuro-Proteomic Analysis Market by Region, 2019 - 2022, USD Million
• TABLE 24 Global Neuro-Proteomic Analysis Market by Region, 2023 - 2030, USD Million
• TABLE 25 Global Neuro-Cellular Manipulation Market by Region, 2019 - 2022, USD Million
• TABLE 26 Global Neuro-Cellular Manipulation Market by Region, 2023 - 2030, USD Million
• TABLE 27 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 28 Global Others Market by Region, 2023 - 2030, USD Million
• TABLE 29 Global Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 30 Global Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 31 Global Diagnostic Laboratories Market by Region, 2019 - 2022, USD Million
• TABLE 32 Global Diagnostic Laboratories Market by Region, 2023 - 2030, USD Million
• TABLE 33 Global Hospitals Market by Region, 2019 - 2022, USD Million
• TABLE 34 Global Hospitals Market by Region, 2023 - 2030, USD Million
• TABLE 35 Global Research & Academic Institute Market by Region, 2019 - 2022, USD Million
• TABLE 36 Global Research & Academic Institute Market by Region, 2023 - 2030, USD Million
• TABLE 37 Global Neuroscience Market by Region, 2019 - 2022, USD Million
• TABLE 38 Global Neuroscience Market by Region, 2023 - 2030, USD Million
• TABLE 39 North America Neuroscience Market, 2019 - 2022, USD Million
• TABLE 40 North America Neuroscience Market, 2023 - 2030, USD Million
• TABLE 41 North America Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 42 North America Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 43 North America Instruments Market by Country, 2019 - 2022, USD Million
• TABLE 44 North America Instruments Market by Country, 2023 - 2030, USD Million
• TABLE 45 North America Consumables Market by Country, 2019 - 2022, USD Million
• TABLE 46 North America Consumables Market by Country, 2023 - 2030, USD Million
• TABLE 47 North America Software & Services Market by Country, 2019 - 2022, USD Million
• TABLE 48 North America Software & Services Market by Country, 2023 - 2030, USD Million
• TABLE 49 North America Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 50 North America Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 51 North America Brain Imaging Market by Country, 2019 - 2022, USD Million
• TABLE 52 North America Brain Imaging Market by Country, 2023 - 2030, USD Million
• TABLE 53 North America Stereotaxic Surgeries Market by Country, 2019 - 2022, USD Million
• TABLE 54 North America Stereotaxic Surgeries Market by Country, 2023 - 2030, USD Million
• TABLE 55 North America Neuro-Microscopy Market by Country, 2019 - 2022, USD Million
• TABLE 56 North America Neuro-Microscopy Market by Country, 2023 - 2030, USD Million
• TABLE 57 North America Neuro-Proteomic Analysis Market by Country, 2019 - 2022, USD Million
• TABLE 58 North America Neuro-Proteomic Analysis Market by Country, 2023 - 2030, USD Million
• TABLE 59 North America Neuro-Cellular Manipulation Market by Country, 2019 - 2022, USD Million
• TABLE 60 North America Neuro-Cellular Manipulation Market by Country, 2023 - 2030, USD Million
• TABLE 61 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 62 North America Others Market by Country, 2023 - 2030, USD Million
• TABLE 63 North America Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 64 North America Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 65 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
• TABLE 66 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
• TABLE 67 North America Hospitals Market by Country, 2019 - 2022, USD Million
• TABLE 68 North America Hospitals Market by Country, 2023 - 2030, USD Million
• TABLE 69 North America Research & Academic Institute Market by Country, 2019 - 2022, USD Million
• TABLE 70 North America Research & Academic Institute Market by Country, 2023 - 2030, USD Million
• TABLE 71 North America Neuroscience Market by Country, 2019 - 2022, USD Million
• TABLE 72 North America Neuroscience Market by Country, 2023 - 2030, USD Million
• TABLE 73 US Neuroscience Market, 2019 - 2022, USD Million
• TABLE 74 US Neuroscience Market, 2023 - 2030, USD Million
• TABLE 75 US Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 76 US Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 77 US Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 78 US Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 79 US Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 80 US Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 81 Canada Neuroscience Market, 2019 - 2022, USD Million
• TABLE 82 Canada Neuroscience Market, 2023 - 2030, USD Million
• TABLE 83 Canada Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 84 Canada Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 85 Canada Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 86 Canada Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 87 Canada Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 88 Canada Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 89 Mexico Neuroscience Market, 2019 - 2022, USD Million
• TABLE 90 Mexico Neuroscience Market, 2023 - 2030, USD Million
• TABLE 91 Mexico Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 92 Mexico Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 93 Mexico Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 94 Mexico Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 95 Mexico Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 96 Mexico Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 97 Rest of North America Neuroscience Market, 2019 - 2022, USD Million
• TABLE 98 Rest of North America Neuroscience Market, 2023 - 2030, USD Million
• TABLE 99 Rest of North America Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 100 Rest of North America Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 101 Rest of North America Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 102 Rest of North America Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 103 Rest of North America Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 104 Rest of North America Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 105 Europe Neuroscience Market, 2019 - 2022, USD Million
• TABLE 106 Europe Neuroscience Market, 2023 - 2030, USD Million
• TABLE 107 Europe Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 108 Europe Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 109 Europe Instruments Market by Country, 2019 - 2022, USD Million
• TABLE 110 Europe Instruments Market by Country, 2023 - 2030, USD Million
• TABLE 111 Europe Consumables Market by Country, 2019 - 2022, USD Million
• TABLE 112 Europe Consumables Market by Country, 2023 - 2030, USD Million
• TABLE 113 Europe Software & Services Market by Country, 2019 - 2022, USD Million
• TABLE 114 Europe Software & Services Market by Country, 2023 - 2030, USD Million
• TABLE 115 Europe Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 116 Europe Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 117 Europe Brain Imaging Market by Country, 2019 - 2022, USD Million
• TABLE 118 Europe Brain Imaging Market by Country, 2023 - 2030, USD Million
• TABLE 119 Europe Stereotaxic Surgeries Market by Country, 2019 - 2022, USD Million
• TABLE 120 Europe Stereotaxic Surgeries Market by Country, 2023 - 2030, USD Million
• TABLE 121 Europe Neuro-Microscopy Market by Country, 2019 - 2022, USD Million
• TABLE 122 Europe Neuro-Microscopy Market by Country, 2023 - 2030, USD Million
• TABLE 123 Europe Neuro-Proteomic Analysis Market by Country, 2019 - 2022, USD Million
• TABLE 124 Europe Neuro-Proteomic Analysis Market by Country, 2023 - 2030, USD Million
• TABLE 125 Europe Neuro-Cellular Manipulation Market by Country, 2019 - 2022, USD Million
• TABLE 126 Europe Neuro-Cellular Manipulation Market by Country, 2023 - 2030, USD Million
• TABLE 127 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 128 Europe Others Market by Country, 2023 - 2030, USD Million
• TABLE 129 Europe Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 130 Europe Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 131 Europe Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
• TABLE 132 Europe Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
• TABLE 133 Europe Hospitals Market by Country, 2019 - 2022, USD Million
• TABLE 134 Europe Hospitals Market by Country, 2023 - 2030, USD Million
• TABLE 135 Europe Research & Academic Institute Market by Country, 2019 - 2022, USD Million
• TABLE 136 Europe Research & Academic Institute Market by Country, 2023 - 2030, USD Million
• TABLE 137 Europe Neuroscience Market by Country, 2019 - 2022, USD Million
• TABLE 138 Europe Neuroscience Market by Country, 2023 - 2030, USD Million
• TABLE 139 Germany Neuroscience Market, 2019 - 2022, USD Million
• TABLE 140 Germany Neuroscience Market, 2023 - 2030, USD Million
• TABLE 141 Germany Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 142 Germany Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 143 Germany Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 144 Germany Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 145 Germany Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 146 Germany Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 147 UK Neuroscience Market, 2019 - 2022, USD Million
• TABLE 148 UK Neuroscience Market, 2023 - 2030, USD Million
• TABLE 149 UK Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 150 UK Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 151 UK Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 152 UK Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 153 UK Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 154 UK Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 155 France Neuroscience Market, 2019 - 2022, USD Million
• TABLE 156 France Neuroscience Market, 2023 - 2030, USD Million
• TABLE 157 France Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 158 France Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 159 France Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 160 France Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 161 France Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 162 France Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 163 Russia Neuroscience Market, 2019 - 2022, USD Million
• TABLE 164 Russia Neuroscience Market, 2023 - 2030, USD Million
• TABLE 165 Russia Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 166 Russia Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 167 Russia Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 168 Russia Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 169 Russia Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 170 Russia Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 171 Spain Neuroscience Market, 2019 - 2022, USD Million
• TABLE 172 Spain Neuroscience Market, 2023 - 2030, USD Million
• TABLE 173 Spain Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 174 Spain Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 175 Spain Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 176 Spain Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 177 Spain Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 178 Spain Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 179 Italy Neuroscience Market, 2019 - 2022, USD Million
• TABLE 180 Italy Neuroscience Market, 2023 - 2030, USD Million
• TABLE 181 Italy Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 182 Italy Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 183 Italy Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 184 Italy Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 185 Italy Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 186 Italy Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 187 Rest of Europe Neuroscience Market, 2019 - 2022, USD Million
• TABLE 188 Rest of Europe Neuroscience Market, 2023 - 2030, USD Million
• TABLE 189 Rest of Europe Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 190 Rest of Europe Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 191 Rest of Europe Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 192 Rest of Europe Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 193 Rest of Europe Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 194 Rest of Europe Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 195 Asia Pacific Neuroscience Market, 2019 - 2022, USD Million
• TABLE 196 Asia Pacific Neuroscience Market, 2023 - 2030, USD Million
• TABLE 197 Asia Pacific Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 198 Asia Pacific Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 199 Asia Pacific Instruments Market by Country, 2019 - 2022, USD Million
• TABLE 200 Asia Pacific Instruments Market by Country, 2023 - 2030, USD Million
• TABLE 201 Asia Pacific Consumables Market by Country, 2019 - 2022, USD Million
• TABLE 202 Asia Pacific Consumables Market by Country, 2023 - 2030, USD Million
• TABLE 203 Asia Pacific Software & Services Market by Country, 2019 - 2022, USD Million
• TABLE 204 Asia Pacific Software & Services Market by Country, 2023 - 2030, USD Million
• TABLE 205 Asia Pacific Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 206 Asia Pacific Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 207 Asia Pacific Brain Imaging Market by Country, 2019 - 2022, USD Million
• TABLE 208 Asia Pacific Brain Imaging Market by Country, 2023 - 2030, USD Million
• TABLE 209 Asia Pacific Stereotaxic Surgeries Market by Country, 2019 - 2022, USD Million
• TABLE 210 Asia Pacific Stereotaxic Surgeries Market by Country, 2023 - 2030, USD Million
• TABLE 211 Asia Pacific Neuro-Microscopy Market by Country, 2019 - 2022, USD Million
• TABLE 212 Asia Pacific Neuro-Microscopy Market by Country, 2023 - 2030, USD Million
• TABLE 213 Asia Pacific Neuro-Proteomic Analysis Market by Country, 2019 - 2022, USD Million
• TABLE 214 Asia Pacific Neuro-Proteomic Analysis Market by Country, 2023 - 2030, USD Million
• TABLE 215 Asia Pacific Neuro-Cellular Manipulation Market by Country, 2019 - 2022, USD Million
• TABLE 216 Asia Pacific Neuro-Cellular Manipulation Market by Country, 2023 - 2030, USD Million
• TABLE 217 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 218 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
• TABLE 219 Asia Pacific Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 220 Asia Pacific Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 221 Asia Pacific Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
• TABLE 222 Asia Pacific Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
• TABLE 223 Asia Pacific Hospitals Market by Country, 2019 - 2022, USD Million
• TABLE 224 Asia Pacific Hospitals Market by Country, 2023 - 2030, USD Million
• TABLE 225 Asia Pacific Research & Academic Institute Market by Country, 2019 - 2022, USD Million
• TABLE 226 Asia Pacific Research & Academic Institute Market by Country, 2023 - 2030, USD Million
• TABLE 227 Asia Pacific Neuroscience Market by Country, 2019 - 2022, USD Million
• TABLE 228 Asia Pacific Neuroscience Market by Country, 2023 - 2030, USD Million
• TABLE 229 China Neuroscience Market, 2019 - 2022, USD Million
• TABLE 230 China Neuroscience Market, 2023 - 2030, USD Million
• TABLE 231 China Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 232 China Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 233 China Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 234 China Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 235 China Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 236 China Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 237 Japan Neuroscience Market, 2019 - 2022, USD Million
• TABLE 238 Japan Neuroscience Market, 2023 - 2030, USD Million
• TABLE 239 Japan Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 240 Japan Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 241 Japan Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 242 Japan Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 243 Japan Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 244 Japan Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 245 India Neuroscience Market, 2019 - 2022, USD Million
• TABLE 246 India Neuroscience Market, 2023 - 2030, USD Million
• TABLE 247 India Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 248 India Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 249 India Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 250 India Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 251 India Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 252 India Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 253 South Korea Neuroscience Market, 2019 - 2022, USD Million
• TABLE 254 South Korea Neuroscience Market, 2023 - 2030, USD Million
• TABLE 255 South Korea Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 256 South Korea Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 257 South Korea Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 258 South Korea Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 259 South Korea Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 260 South Korea Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 261 Singapore Neuroscience Market, 2019 - 2022, USD Million
• TABLE 262 Singapore Neuroscience Market, 2023 - 2030, USD Million
• TABLE 263 Singapore Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 264 Singapore Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 265 Singapore Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 266 Singapore Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 267 Singapore Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 268 Singapore Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 269 Malaysia Neuroscience Market, 2019 - 2022, USD Million
• TABLE 270 Malaysia Neuroscience Market, 2023 - 2030, USD Million
• TABLE 271 Malaysia Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 272 Malaysia Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 273 Malaysia Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 274 Malaysia Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 275 Malaysia Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 276 Malaysia Neuroscience Market by End User, 2023 - 2030, USD Million
• TABLE 277 Rest of Asia Pacific Neuroscience Market, 2019 - 2022, USD Million
• TABLE 278 Rest of Asia Pacific Neuroscience Market, 2023 - 2030, USD Million
• TABLE 279 Rest of Asia Pacific Neuroscience Market by Component, 2019 - 2022, USD Million
• TABLE 280 Rest of Asia Pacific Neuroscience Market by Component, 2023 - 2030, USD Million
• TABLE 281 Rest of Asia Pacific Neuroscience Market by Technology, 2019 - 2022, USD Million
• TABLE 282 Rest of Asia Pacific Neuroscience Market by Technology, 2023 - 2030, USD Million
• TABLE 283 Rest of Asia Pacific Neuroscience Market by End User, 2019 - 2022, USD Million
• TABLE 284 Rest of Asia Pacific Neuroscience Market by End User, 2023 - 2030, USD Million

The Global Neuroscience Market size is expected to reach $64 billion by 2030, rising at a market growth of 5.5% CAGR during the forecast period.

Neurological diseases are common among older adults, with a prevalence rate ranging from 5% to 55% in individuals aged 55 and above. These conditions account for over 37% of the years of healthy life lost due to disability among adults aged 15 and above. Therefore, the Stereotaxic Surgeries segment would capture 1/5th share in the market by 2030. Stereotaxic neurosurgery (or stereotactic brain surgery) is the method of finding surgical targets within the brain relative to an external frame of reference. Previously, accomplishing this required momentarily fastening a mechanical frame to the patient's scalp or skull. Typically, this surgery aims to eliminate an anomaly identified by an MRI or CT scan. Recent developments in computing are enhancing these methods to enable greater surgical planning and intraoperative information.

The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In July, 2023, GE HealthCare Technologies, Inc. signed a partnership with Elekta to provide radiation therapy solutions within the Indian market. The partnership expands GE HealthCare's oncology offerings and would allow it to provide an efficient cancer care portfolio to Indian customers. Additionally, In January, 2023, Koninklijke Philips N.V. partnered with Masimo, to integrate its patient monitoring portfolio with Masimo W1.

Based on the Analysis presented in the KBV Cardinal matrix; Danaher Corporation and Abbott Laboratories are the forerunners in the Market. Companies such as Terumo Corporation, Medtronic PLC, Stryker Corporation are some of the key innovators in the Market. In April, 2023, Medtronic PLC partnered with Qure.ai, to provide advanced solutions for stroke management in the Indian market.

COVID-19 Impact Analysis

The COVID-19 pandemic had a severe impact on the world's economy. The outbreak has affected almost all industries, either positively or negatively. The market was negatively impacted by the pandemic outbreak in the initial months. Most countries faced more pressure to improve their mental health services because of the pandemic. Despite an established late-stage pharmaceutical pipeline, the COVID-19 pandemic also hampered clinical trial procedures, R&D, and pipeline products, and these factors had a negative effect on the growth of the market. Therefore, despite the negative impact on the market during the early stages, the market will experience rapid growth in the coming years.

Market Growth Factors

Favorable reimbursement for treatments and neuroimaging

Rising government spending on healthcare infrastructure in developed nations is predicted to drive the growth of the market. For example, Medicare spending increased by 8.4% to $900.8 billion in 2021, or 21% of all national health expenditure (NHE), and Medicaid spending increased by 9.2% to $734.0 billion, or 17% of all NHE, according to the Centers for Medicare and Medicaid Services. In the U.S., interest in all medical devices, including brain equipment, will rise due to this rising trend in government spending. Therefore, the availability of reimbursement of neuroscience treatment in most nations is significant factor propelling the growth of the market.

Developments in neurological R&D activities

The most effective imaging and neuroscience research tool is magnetic resonance imaging (MRI). In addition to the exceptional functional details of the central nervous system (CNS), it offers morphological images with the highest quality spatial resolution and unmatched soft tissue contrast. A project to develop and implement a novel real-time functional magnetic resonance imaging (rt-fMRI)-based neurofeedback (NF) training paradigm was initiated, according to a research study titled "A Novel Brain-Computer January 2021 publication of "Interface Virtual Environment for Neurofeedback During Functional MRI." Therefore, the rising research and development in this filed is expected the drive the growth of the market.

Market Restraining Factors

Complexity of the brain

The brain appears to be the most complex compared to other human bodily organs. Research indicates that a significant portion of the human genome contributes to the development of brain structure, connectional patterns, and neurochemistry. The brain is responsible for many functions, including movement induction, sensation mediation, and control over other bodily organs. Its operation provides the basis for perception, cognition, emotion, and creative expression. Neuroscience also needs to account for the variations among people brought on by environmental and inherited variables. Hence, the complexity of how these components interact and contribute to different brain processes presents a significant obstacle that limits market expansion.

Component Outlook

On the basis of component, the market is segmented into instruments, consumables, and software & services. In 2022, the instruments segment dominated the n market with the maximum revenue share. The growth of the segment is due to the arrival of new instrument equipment for detecting and treating neurological illnesses. A specific kind of instrument used in neuroscience is an optogenetics device. Other types include microscopy devices, electrophysiological instruments, and MRI equipment.

Technology Outlook

Based on technology, the market is fragmented into brain imaging, neuro-microscopy, stereotaxic surgeries, neuro-proteomic analysis, neuro-cellular manipulation, and others. The neuro-microscopy segment garnered a significant revenue share in the in 2022. The demand for neuro-microscopy is rising due to the increasing rate of technological development in areas like genetic cell labeling and optogenetics. To observe the nervous system at the cellular and subcellular levels and to contextualize any molecular modifications, microscopy techniques are essential.

End User Outlook

By end-user, the market is classified into hospitals, diagnostic laboratories, and research & academic institute. In 2022, the diagnostic laboratories segment registered the highest revenue share in the market. The broad range of neurological devices' applications in diagnostic laboratories and the public's growing awareness of the benefits of early disease diagnosis are attributed for the growth of the segment. Using electroencephalograms (EEG), electromyograms (EMG), CT scans, MRIs, and other neurological diagnostic tools is common in diagnostic facilities.

Regional Outlook

Region wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region witnessed the largest revenue share in the market. The growth of the market in this region can be attributed to the region's significant concentration of companies involved in creating, manufacturing, and distributing technologies used to diagnose and treat neurological patients. The primary drivers of market expansion in this region are the rise in disease prevalence and awareness, as well as the presence of key market participants.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss AG, Danaher Corporation, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Terumo Corporation, B. Braun Melsungen AG, Medtronic PLC, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories

Recent Strategies Deployed in Neuroscience Market

Partnerships, Collaborations & Agreements:

Jul-2023: GE HealthCare Technologies, Inc. signed a partnership with Elekta, a radiation therapy solutions provider, to provide radiation therapy solutions within the Indian market. The partnership expands GE HealthCare's oncology offerings and would allow it to provide an efficient cancer care portfolio to Indian customers.

Apr-2023: Medtronic PLC partnered with Qure.ai, a medical AI solutions provider, to provide advanced solutions for stroke management in the Indian market. The partnership would facilitate the two companies in developing efficient workflow solutions that would help in improving stroke care across India.

Jan-2023: Koninklijke Philips N.V. partnered with Masimo, a medical device manufacturing company, to integrate its patient monitoring portfolio with Masimo W1. The products and solutions developed in the course of the partnership would facilitate physicians around the world to facilitate patient care around the world.

Jun-2022: Stryker Corporation announced a partnership with Carmeda, a medical technology company, to integrate its diverter technology with Carmeda's active heparin coating. The combined expertise of the two companies would lead to better care for patients with brain aneurysms.

Apr-2022: GE HealthCare Technologies, Inc. entered a partnership with Medtronic, a medical device manufacturing company, to develop advanced patient care solutions. The partnership would facilitate the two companies in providing solutions for efficient productivity in Office Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs).

Feb-2022: Terumo Corporation signed a distribution partnership with Corazon, Inc., a neurovascular disease management solutions provider. Through the partnership, Terumo would gain a strong foothold in the digital healthcare solutions market.

Nov-2021: Medtronic PLC signed a research partnership with Rune Labs, a neurological disease treatment drug developer, to gain insights on neurostimulation effects. The partnership features the integration of the two companies' offerings and would facilitate brain surgeons around the world in better decision-making processes for patient care management.

Jun-2021: B. Braun Melsungen AG partnered with Merck, a pharmaceutical company, to develop advanced bioelectronic devices. The partnership would enable B. Braun to gain insights and improve the performance of its functional neurosurgery offerings.

Apr-2021: Medtronic PLC came into partnership with Surgical Theater, a surgical VR solutions provider, to integrate its StealthStation S8 surgical navigation system with Surgical Theater's SyncAR augmented reality (AR) technology. The partnership would facilitate the development of solutions that would facilitate the surgeons to get improved visualization for brain surgeries.

Jan-2021: Carl Zeiss AG came into partnership with Max Planck Florida, a neuroscience research institute, to integrate its Airyscan 2 with GRadient INdex (GRIN) lenses for neuroscience research. The partnership would provide meaningful insights to Zeiss that would facilitate a better product creation process.

Mergers & Acquisition:

Aug-2022: Boston Scientific Corporation took over Obsidio, Inc., a pharmaceutical company. The acquisition enhances Boston Scientific's interventional embolization and oncology offerings.

Sep-2021: Abbott Laboratories acquired Walk Vascular, LLC, a blood clot removal solutions provider. The acquisition complements Abbot's vascular device portfolio and would further enable it to provide innovative endovascular therapy solutions.

Jun-2021: Danaher Corporation announced the acquisition of Aldevron, a biotechnology company. The acquisition enhances Danaher's genomic medicine capabilities.

Jun-2021: Danaher Corporation acquired Precision Nanosystems (PNI), a biotechnology company. The acquisition strengthens Danaher's lipid service offerings by adding PNI's GenVoy delivery technology to its portfolio.

Product Launches and Product Expansions:

Jul-2023: Stryker Corporation introduced The Q Guidance System, a software used for facilitating surgeons in carrying out cranial procedures. The Q Guidance System can be paired with Stryker's cranial software for usage in transsphenoidal and skull base procedures. Additionally, the system features Stryker's high-quality cameras for tracking during surgical procedures.

Jun-2023: Carl Zeiss AG released ZEISS Volutome, an in-chamber ultramicrotome for use in ZEISS field emission scanning electron microscopes. The ZEISS Volutome features a ZEISS Volume BSD image detector for high-contrast image capture even in low-voltage situations. Additionally, it has a ZEISS Volutome stage that is used for capturing large volumes of EM datasets.

May-2023: Koninklijke Philips N.V. announced the launch of Philips CT 3500, an AI-powered computed tomography (CT) system. The system features internal and external proactive monitoring sensors for gaining insights into vital performance indicators. Additionally, it has Philip's flat panel detector technology for low-cost treatment of patients.

Trials and Approvals:

Jul-2023: The US Food and Drug Administration (FDA) approved Boston Scientific Corporation's Vercise Neural Navigator 5 Software. The Vercise Neural Navigator 5 Software is a deep brain stimulation (DBS) solution used for the treatment of Parkinson's disease or tremors.

Mar-2023: Abbott Laboratories received approval from The US FDA for its Alinity I laboratory traumatic brain injury (TBI) blood test. The Alinity I laboratory traumatic brain injury (TBI) blood test is used for the measurement of biomarkers in blood plasma and serum for the detection of brain injury.

Scope of the Study

Market Segments covered in the Report:

By Component

• Instruments
• Consumables
• Software & Services

By Technology

• Brain Imaging
• Stereotaxic Surgeries
• Neuro-Microscopy
• Neuro-Proteomic Analysis
• Neuro-Cellular Manipulation
• Others

By End User

• Diagnostic Laboratories
• Hospitals
• Research & Academic Institute

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Carl Zeiss AG
• Danaher Corporation
• Koninklijke Philips N.V.
• GE HealthCare Technologies, Inc.
• Terumo Corporation
• B. Braun Melsungen AG
• Medtronic PLC
• Stryker Corporation
• Boston Scientific Corporation
• Abbott Laboratories

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Neuroscience Market, by Component
  • 1.4.2 Global Neuroscience Market, by Technology
  • 1.4.3 Global Neuroscience Market, by End User
  • 1.4.4 Global Neuroscience Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
  • 4.2.4 Trials and Approvals
• 4.3 Top Winning Strategies
  • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Oct- 2023, Jul) Leading Players
• 4.4 Porter Five Forces Analysis

Chapter 5. Global Neuroscience Market by Component

• 5.1 Global Instruments Market by Region
• 5.2 Global Consumables Market by Region
• 5.3 Global Software & Services Market by Region

Chapter 6. Global Neuroscience Market by Technology

• 6.1 Global Brain Imaging Market by Region
• 6.2 Global Stereotaxic Surgeries Market by Region
• 6.3 Global Neuro-Microscopy Market by Region
• 6.4 Global Neuro-Proteomic Analysis Market by Region
• 6.5 Global Neuro-Cellular Manipulation Market by Region
• 6.6 Global Others Market by Region

Chapter 7. Global Neuroscience Market by End User

• 7.1 Global Diagnostic Laboratories Market by Region
• 7.2 Global Hospitals Market by Region
• 7.3 Global Research & Academic Institute Market by Region

Chapter 8. Global Neuroscience Market by Region

• 8.1 North America Neuroscience Market
  • 8.1.1 North America Neuroscience Market by Component
    • 8.1.1.1 North America Instruments Market by Country
    • 8.1.1.2 North America Consumables Market by Country
    • 8.1.1.3 North America Software & Services Market by Country
  • 8.1.2 North America Neuroscience Market by Technology
    • 8.1.2.1 North America Brain Imaging Market by Country
    • 8.1.2.2 North America Stereotaxic Surgeries Market by Country
    • 8.1.2.3 North America Neuro-Microscopy Market by Country
    • 8.1.2.4 North America Neuro-Proteomic Analysis Market by Country
    • 8.1.2.5 North America Neuro-Cellular Manipulation Market by Country
    • 8.1.2.6 North America Others Market by Country
  • 8.1.3 North America Neuroscience Market by End User
    • 8.1.3.1 North America Diagnostic Laboratories Market by Country
    • 8.1.3.2 North America Hospitals Market by Country
    • 8.1.3.3 North America Research & Academic Institute Market by Country
  • 8.1.4 North America Neuroscience Market by Country
    • 8.1.4.1 US Neuroscience Market
      • 8.1.4.1.1 US Neuroscience Market by Component
      • 8.1.4.1.2 US Neuroscience Market by Technology
      • 8.1.4.1.3 US Neuroscience Market by End User
    • 8.1.4.2 Canada Neuroscience Market
      • 8.1.4.2.1 Canada Neuroscience Market by Component
      • 8.1.4.2.2 Canada Neuroscience Market by Technology
      • 8.1.4.2.3 Canada Neuroscience Market by End User
    • 8.1.4.3 Mexico Neuroscience Market
      • 8.1.4.3.1 Mexico Neuroscience Market by Component
      • 8.1.4.3.2 Mexico Neuroscience Market by Technology
      • 8.1.4.3.3 Mexico Neuroscience Market by End User
    • 8.1.4.4 Rest of North America Neuroscience Market
      • 8.1.4.4.1 Rest of North America Neuroscience Market by Component
      • 8.1.4.4.2 Rest of North America Neuroscience Market by Technology
      • 8.1.4.4.3 Rest of North America Neuroscience Market by End User
• 8.2 Europe Neuroscience Market
  • 8.2.1 Europe Neuroscience Market by Component
    • 8.2.1.1 Europe Instruments Market by Country
    • 8.2.1.2 Europe Consumables Market by Country
    • 8.2.1.3 Europe Software & Services Market by Country
  • 8.2.2 Europe Neuroscience Market by Technology
    • 8.2.2.1 Europe Brain Imaging Market by Country
    • 8.2.2.2 Europe Stereotaxic Surgeries Market by Country
    • 8.2.2.3 Europe Neuro-Microscopy Market by Country
    • 8.2.2.4 Europe Neuro-Proteomic Analysis Market by Country
    • 8.2.2.5 Europe Neuro-Cellular Manipulation Market by Country
    • 8.2.2.6 Europe Others Market by Country
  • 8.2.3 Europe Neuroscience Market by End User
    • 8.2.3.1 Europe Diagnostic Laboratories Market by Country
    • 8.2.3.2 Europe Hospitals Market by Country
    • 8.2.3.3 Europe Research & Academic Institute Market by Country
  • 8.2.4 Europe Neuroscience Market by Country
    • 8.2.4.1 Germany Neuroscience Market
      • 8.2.4.1.1 Germany Neuroscience Market by Component
      • 8.2.4.1.2 Germany Neuroscience Market by Technology
      • 8.2.4.1.3 Germany Neuroscience Market by End User
    • 8.2.4.2 UK Neuroscience Market
      • 8.2.4.2.1 UK Neuroscience Market by Component
      • 8.2.4.2.2 UK Neuroscience Market by Technology
      • 8.2.4.2.3 UK Neuroscience Market by End User
    • 8.2.4.3 France Neuroscience Market
      • 8.2.4.3.1 France Neuroscience Market by Component
      • 8.2.4.3.2 France Neuroscience Market by Technology
      • 8.2.4.3.3 France Neuroscience Market by End User
    • 8.2.4.4 Russia Neuroscience Market
      • 8.2.4.4.1 Russia Neuroscience Market by Component
      • 8.2.4.4.2 Russia Neuroscience Market by Technology
      • 8.2.4.4.3 Russia Neuroscience Market by End User
    • 8.2.4.5 Spain Neuroscience Market
      • 8.2.4.5.1 Spain Neuroscience Market by Component
      • 8.2.4.5.2 Spain Neuroscience Market by Technology
      • 8.2.4.5.3 Spain Neuroscience Market by End User
    • 8.2.4.6 Italy Neuroscience Market
      • 8.2.4.6.1 Italy Neuroscience Market by Component
      • 8.2.4.6.2 Italy Neuroscience Market by Technology
      • 8.2.4.6.3 Italy Neuroscience Market by End User
    • 8.2.4.7 Rest of Europe Neuroscience Market
      • 8.2.4.7.1 Rest of Europe Neuroscience Market by Component
      • 8.2.4.7.2 Rest of Europe Neuroscience Market by Technology
      • 8.2.4.7.3 Rest of Europe Neuroscience Market by End User
• 8.3 Asia Pacific Neuroscience Market
  • 8.3.1 Asia Pacific Neuroscience Market by Component
    • 8.3.1.1 Asia Pacific Instruments Market by Country
    • 8.3.1.2 Asia Pacific Consumables Market by Country
    • 8.3.1.3 Asia Pacific Software & Services Market by Country
  • 8.3.2 Asia Pacific Neuroscience Market by Technology
    • 8.3.2.1 Asia Pacific Brain Imaging Market by Country
    • 8.3.2.2 Asia Pacific Stereotaxic Surgeries Market by Country
    • 8.3.2.3 Asia Pacific Neuro-Microscopy Market by Country
    • 8.3.2.4 Asia Pacific Neuro-Proteomic Analysis Market by Country
    • 8.3.2.5 Asia Pacific Neuro-Cellular Manipulation Market by Country
    • 8.3.2.6 Asia Pacific Others Market by Country
  • 8.3.3 Asia Pacific Neuroscience Market by End User
    • 8.3.3.1 Asia Pacific Diagnostic Laboratories Market by Country
    • 8.3.3.2 Asia Pacific Hospitals Market by Country
    • 8.3.3.3 Asia Pacific Research & Academic Institute Market by Country
  • 8.3.4 Asia Pacific Neuroscience Market by Country
    • 8.3.4.1 China Neuroscience Market
      • 8.3.4.1.1 China Neuroscience Market by Component
      • 8.3.4.1.2 China Neuroscience Market by Technology
      • 8.3.4.1.3 China Neuroscience Market by End User
    • 8.3.4.2 Japan Neuroscience Market
      • 8.3.4.2.1 Japan Neuroscience Market by Component
      • 8.3.4.2.2 Japan Neuroscience Market by Technology
      • 8.3.4.2.3 Japan Neuroscience Market by End User
    • 8.3.4.3 India Neuroscience Market
      • 8.3.4.3.1 India Neuroscience Market by Component
      • 8.3.4.3.2 India Neuroscience Market by Technology
      • 8.3.4.3.3 India Neuroscience Market by End User
    • 8.3.4.4 South Korea Neuroscience Market
      • 8.3.4.4.1 South Korea Neuroscience Market by Component
      • 8.3.4.4.2 South Korea Neuroscience Market by Technology
      • 8.3.4.4.3 South Korea Neuroscience Market by End User
    • 8.3.4.5 Singapore Neuroscience Market
      • 8.3.4.5.1 Singapore Neuroscience Market by Component
      • 8.3.4.5.2 Singapore Neuroscience Market by Technology
      • 8.3.4.5.3 Singapore Neuroscience Market by End User
    • 8.3.4.6 Malaysia Neuroscience Market
      • 8.3.4.6.1 Malaysia Neuroscience Market by Component
      • 8.3.4.6.2 Malaysia Neuroscience Market by Technology
      • 8.3.4.6.3 Malaysia Neuroscience Market by End User
    • 8.3.4.7 Rest of Asia Pacific Neuroscience Market
      • 8.3.4.7.1 Rest of Asia Pacific Neuroscience Market by Component
      • 8.3.4.7.2 Rest of Asia Pacific Neuroscience Market by Technology
      • 8.3.4.7.3 Rest of Asia Pacific Neuroscience Market by End User
• 8.4 LAMEA Neuroscience Market
  • 8.4.1 LAMEA Neuroscience Market by Component
    • 8.4.1.1 LAMEA Instruments Market by Country
    • 8.4.1.2 LAMEA Consumables Market by Country
    • 8.4.1.3 LAMEA Software & Services Market by Country
  • 8.4.2 LAMEA Neuroscience Market by Technology
    • 8.4.2.1 LAMEA Brain Imaging Market by Country
    • 8.4.2.2 LAMEA Stereotaxic Surgeries Market by Country
    • 8.4.2.3 LAMEA Neuro-Microscopy Market by Country
    • 8.4.2.4 LAMEA Neuro-Proteomic Analysis Market by Country
    • 8.4.2.5 LAMEA Neuro-Cellular Manipulation Market by Country
    • 8.4.2.6 LAMEA Others Market by Country
  • 8.4.3 LAMEA Neuroscience Market by End User
    • 8.4.3.1 LAMEA Diagnostic Laboratories Market by Country
    • 8.4.3.2 LAMEA Hospitals Market by Country
    • 8.4.3.3 LAMEA Research & Academic Institute Market by Country
  • 8.4.4 LAMEA Neuroscience Market by Country
    • 8.4.4.1 Brazil Neuroscience Market
      • 8.4.4.1.1 Brazil Neuroscience Market by Component
      • 8.4.4.1.2 Brazil Neuroscience Market by Technology
      • 8.4.4.1.3 Brazil Neuroscience Market by End User
    • 8.4.4.2 Argentina Neuroscience Market
      • 8.4.4.2.1 Argentina Neuroscience Market by Component
      • 8.4.4.2.2 Argentina Neuroscience Market by Technology
      • 8.4.4.2.3 Argentina Neuroscience Market by End User
    • 8.4.4.3 UAE Neuroscience Market
      • 8.4.4.3.1 UAE Neuroscience Market by Component
      • 8.4.4.3.2 UAE Neuroscience Market by Technology
      • 8.4.4.3.3 UAE Neuroscience Market by End User
    • 8.4.4.4 Saudi Arabia Neuroscience Market
      • 8.4.4.4.1 Saudi Arabia Neuroscience Market by Component
      • 8.4.4.4.2 Saudi Arabia Neuroscience Market by Technology
      • 8.4.4.4.3 Saudi Arabia Neuroscience Market by End User
    • 8.4.4.5 South Africa Neuroscience Market
      • 8.4.4.5.1 South Africa Neuroscience Market by Component
      • 8.4.4.5.2 South Africa Neuroscience Market by Technology
      • 8.4.4.5.3 South Africa Neuroscience Market by End User
    • 8.4.4.6 Nigeria Neuroscience Market
      • 8.4.4.6.1 Nigeria Neuroscience Market by Component
      • 8.4.4.6.2 Nigeria Neuroscience Market by Technology
      • 8.4.4.6.3 Nigeria Neuroscience Market by End User
    • 8.4.4.7 Rest of LAMEA Neuroscience Market
      • 8.4.4.7.1 Rest of LAMEA Neuroscience Market by Component
      • 8.4.4.7.2 Rest of LAMEA Neuroscience Market by Technology
      • 8.4.4.7.3 Rest of LAMEA Neuroscience Market by End User

Chapter 9. Company Profiles

• 9.1 Carl Zeiss AG
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Segmental and Regional Analysis
  • 9.1.4 Research & Development Expenses
  • 9.1.5 Recent strategies and developments:
    • 9.1.5.1 Partnerships, Collaborations, and Agreements:
    • 9.1.5.2 Product Launches and Product Expansions:
  • 9.1.6 SWOT Analysis
• 9.2 Danaher Corporation
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expense
  • 9.2.5 Recent strategies and developments:
    • 9.2.5.1 Acquisition and Mergers:
  • 9.2.6 SWOT Analysis
• 9.3 Abbott Laboratories
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 Recent strategies and developments:
    • 9.3.5.1 Trials and Approvals:
    • 9.3.5.2 Acquisition and Mergers:
  • 9.3.6 SWOT Analysis
• 9.4 Koninklijke Philips N.V.
  • 9.4.1 Company Overview
  • 9.4.2 Financial Analysis
  • 9.4.3 Segmental and Regional Analysis
  • 9.4.4 Research & Development Expense
  • 9.4.5 Recent strategies and developments:
    • 9.4.5.1 Partnerships, Collaborations, and Agreements:
    • 9.4.5.2 Product Launches and Product Expansions:
    • 9.4.5.3 Acquisition and Mergers:
  • 9.4.6 SWOT Analysis
• 9.5 B. Braun Melsungen AG
  • 9.5.1 Company Overview
  • 9.5.2 Financial Analysis
  • 9.5.3 Segmental and Regional Analysis
  • 9.5.4 Research & Development Expenses
  • 9.5.5 Recent strategies and developments:
    • 9.5.5.1 Partnerships, Collaborations, and Agreements:
  • 9.5.6 SWOT Analysis
• 9.6 Medtronic PLC
  • 9.6.1 Company overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Segmental and Regional Analysis
  • 9.6.4 Research & Development Expenses
  • 9.6.5 Recent strategies and developments:
    • 9.6.5.1 Partnerships, Collaborations, and Agreements:
  • 9.6.6 SWOT Analysis
• 9.7 Boston Scientific Corporation
  • 9.7.1 Company Overview
  • 9.7.2 Financial Analysis
  • 9.7.3 Segmental and Regional Analysis
  • 9.7.4 Research & Development Expense
  • 9.7.5 Recent strategies and developments:
    • 9.7.5.1 Trials and Approvals:
    • 9.7.5.2 Acquisition and Mergers:
  • 9.7.6 SWOT Analysis
• 9.8 Terumo Corporation
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Segmental and Regional Analysis
  • 9.8.4 Research & Development Expenses
  • 9.8.5 Recent strategies and developments:
    • 9.8.5.1 Partnerships, Collaborations, and Agreements:
  • 9.8.6 SWOT Analysis
• 9.9 GE HealthCare Technologies, Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Segmental and Regional Analysis
  • 9.9.4 Research & Development Expenses
  • 9.9.5 Recent strategies and developments:
    • 9.9.5.1 Partnerships, Collaborations, and Agreements:
  • 9.9.6 SWOT Analysis
• 9.10. Stryker Corporation
  • 9.10.1 Company Overview
  • 9.10.2 Financial Analysis
  • 9.10.3 Segmental and Regional Analysis
  • 9.10.4 Research & Development Expense
  • 9.10.5 Recent strategies and developments:
    • 9.10.5.1 Partnerships, Collaborations, and Agreements:
    • 9.10.5.2 Product Launches and Product Expansions:
    • 9.10.5.3 Trials and Approvals:
  • 9.10.6 SWOT Analysis

Chapter 10. Winning Imperative for Neuroscience Market